Tag: Innovation Health and Wealth

Latest articles

Image of brain scan to show People with neurological conditions lose out due to COVID-19 delays

People with neurological conditions lose out due to COVID-19 delays

In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Image of a head with a cloud brain to show Post COVID-19 mental health crisis awaits

Without support for services post COVID-19 mental health crisis awaits

The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scale held by a hand with one business person on the left and a group balancing on the right to show Crisis or crossroads? Where next for key account management post-COVID?

Crisis or crossroads? Key account management post-COVID

Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Image of a contract being signed by two people with a certification stamp to show European Commission approves extended Invokana ® (canagliflozin) indication

European Commission approves extended Invokana ® (canagliflozin) indication

The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription